Changing the treatment
paradigm
Developing miRNA therapeutics for age-related and fibrotic disorders
“Lack of activity destroys the good condition of every human being, while movement and methodical physical exercise save it and preserve it”
Plato
Our Technology
Healthy Ageing through musultoskeletal health
MicroRNA therapies have almost limitless therapeutic potential
Our Pipeline
Changing the treatment paradigm
As Causeway’s Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age-related indications that have the potential re-define what it means to grow old.
Programs
As Causeway’s Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age-related indications that have the potential re-define what it means to grow old.
OsteoMiR
for Osteoarthritis
DermaMiR™
for skin-ageing
TenoMiR
for Tendinopathy
About Us
Our goal is to develop therapies that treat the most common musculoskeletal diseases, such as osteoarthritis and tendinopathy, re-defining what old age looks and feels like.